Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 354-358

  Rudolph, Tanja K ^a,b   Schaper, Neele ^b   Klinke, Anna ^a,b   Demir, Cagri ^b   Goldmann, Britta ^b   Lau, Denise ^b   Köster, Ralf ^c   Hellmich, Martin ^a   Meinertz, Thomas ^b   Baldus, Stephan ^a,b   Rudolph, Volker ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c Johanniter Krankenhaus   (Germany)

Author keywords

Coronary artery disease; Myeloperoxidase; Plaque burden

Indexed keywords

HEPARIN; MYELOPEROXIDASE;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY MYELOPEROXIDASE DEPOSITION; DENSITOMETRY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CORONARY ARTERY DISEASE; MYELOPEROXIDASE; PLAQUE BURDEN;

AGED; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DENSITOMETRY; FEMALE; HEPARIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PEROXIDASE; PLAQUE, ATHEROSCLEROTIC; REGRESSION ANALYSIS;

EID: 84888088391     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.09.016     Document Type: Article

References (29)

1. Shishehbor M.H., Aviles R.J., Brennan M.L., et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAm Med Assoc 2003, 289:1675-1680.
2. Eiserich J.P., Baldus S., Brennan M.L., et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002, 296:2391-2394.
3. Lau D., Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 2006, 111:16-26.
4. Podrez E.A., Schmitt D., Hoff H.F., Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form invitro. JClin Invest 1999, 103:1547-1560.
5. Bergt C., Pennathur S., Fu X., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 2004, 101:13032-13037.
6. Zhang C., Reiter C., Eiserich J.P., et al. L-arginine chlorination products inhibit endothelial nitric oxide production. JBiol Chem 2001, 276:27159-27165.
7. Baldus S., Eiserich J.P., Mani A., et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. JClin Invest 2001, 108:1759-1770.
8. Lau D., Mollnau H., Eiserich J.P., et al. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 2005, 102:431-436.
9. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. JBiol Chem 2001, 276:41279-41287.
10. Rudolph V., Andrié R.P., Rudolph T.K., et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 2010, 16:470-474.
11. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndrome. Circulation 2002, 106:2894-2900.
12. Klinke A., Nussbaum C., Kubala L., et al. Myeloperoxidase attracts neutrophils by physical forces. Blood 2010.
13. Baldus S., Rudolph V., Roiss M., et al. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006, 113:1871-1878.
14. Rudolph V., Steven D., Gehling U.M., et al. Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease. Free Radic Biol Med 2007, 42:460-465.
15. Gronenschild E., Janssen J., Tijdens F. CAAS. II: a second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994, 33:61-75.
16. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
17. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. NEngl J Med 2003, 349:1595-1604.
18. Mocatta T.J., Pilbrow A.P., Cameron V.A., et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. JAm Coll Cardiol 2007, 49:1993-2000.
19. Tang W.H., Tong W., Troughton R.W., et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. JAm Coll Cardiol 2007, 49:2364-2370.
20. Brevetti G., Schiano V., Laurenzano E., et al. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J 2008, 29:224-230.
21. Exner M., Minar E., Mlekusch W., et al. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. JAm Coll Cardiol 2006, 47:2212-2218.
22. Meuwese M.C., Stroes E.S., Hazen S.L., et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. JAm Coll Cardiol 2007, 50:159-165.
23. Kubala L., Lu G., Baldus S., Berglund L., Eiserich J.P. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta 2008, 394:59-62.
24. Daphna E.M., Michaela S., Eynat P., Irit A., Rimon S. Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol Cell Biochem 1998, 183:55-61.
25. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., Maseri A. Widespread coronary inflammation in unstable angina. NEngl J Med 2002, 347:5-12.
26. Rudolph T.K., Wipper S., Reiter B., et al. Myeloperoxidase deficiency preserves vasomotor function in humans. Eur Heart J 2011, 33:1625-1634.
27. Inoue T., Komoda H., Nonaka M., Kameda M., Uchida T. Node K.Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 2008, 124:319-325.
28. Paulsson J., Dadfar E., Held C., Jacobson S.H., Lundahl J. Activation of peripheral and invivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007, 192:328-334.
29. Gonzalez M.A., Selwyn A.P. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003, 115:99-106.